Stability indicating HPLC method for simultaneous determination of moxifloxacin hydrochloride and ketorolac tromethamine in pharmaceutical formulations
AUTOR(ES)
Razzaq, Syed Naeem, Khan, Islam Ullah, Ashfaq, Muhammad, Mariam, Irfana
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2012
RESUMO
A simple, RP-HPLC method was established for determining moxifloxacin and ketorolac in pharmaceutical formulations. Moxifloxacin, ketorolac and their degradation products were separated using C8 column with methanol and phosphate buffer pH 3.0 (55:45 v/v) as the mobile phase. Detection was performed at 243 nm using a diode array detector. The method was validated using ICH guidelines and was linear in the range 20-140 µg mL-1 for both analytes. Good separation of both the analytes and their degradation products was achieved using this method. The developed method can be applied successfully for the determination of moxifloxacin and ketorolac.
Documentos Relacionados
- Simultaneous estimation of rosuvastatin and amlodipine in pharmaceutical formulations using stability indicating HPLC method
- Stability-indicating RP-HPLC method for simultaneous determination of gatifloxacin and flurbiprofen in binary combination
- Stability indicating RP-HPLC method for simultaneous determination of gatifloxacin and dexamethasone in binary combination
- Simultaneous RP-HPLC determination of sparfloxacin and dexamethasone in pharmaceutical formulations
- A validated stability indicating HPLC method for the determination of process-related impurities in pantoprazole bulk drug and formulations